NVO Weight Loss Drug Disappoints, RDFN Acquisition, Airline Price Targets Slashed

Market weakness continued this morning, including in international companies like Novo Nordisk (NVO). Its next-gen weight loss drug trial results weren't enough to draw investors in. American Airlines (AAL), United Airlines (UAL) and Delta Airlines (DAL) all got price target cuts from Bernstein. One major rally was seen in Redfin (RDFN) with Rocket Companies looking to acquire the real estate small cap. Diane King Hall has more on the morning's biggest movers.

======== Schwab Network ========

Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe

Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185

Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7

Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch

Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore

Watch on DistroTV - https://www.distro.tv/live/schwab-network/

About Schwab Network - https://schwabnetwork.com/about

Fler avsnitt av Schwab Network